Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Clinical proof – Siemens' Artis Q.zen minimizes dose in cardiology

02.09.2013
- Significant dose reductions in electrophysiological examinations and interventional cardiology
- Angiography system with unique x-ray tube and detector

The new Artis Q.zen angiography system from Siemens has proven itself in everyday clinical practice. The system has been in use since November 2012 at the Basel University Hospital in Switzerland where both patients and staff benefit from the low radiation dose that an entirely novel technology has made possible.



"My team spends about three to four hours a day in the Electrophysiology Laboratory (EP) in connection with about eight to ten operations. This is why reducing the dose is so important," says Prof. Stefan Osswald, head of the cardiology department. With Artis Q.zen, Siemens is demonstrating its innovative strength as part of the global "Agenda 2013" Sector initiative.

Studies show that on average one in four people suffer from atrial fibrillation, the most widespread form of cardiac arrhythmia, at some stage during their lives. A further increase can be expected as a result of demographic change. Electrophysiological studies and interventions can be used to examine and treat a large number of patients. This involves ablating tiny points in the myocardial tissue using an ablation catheter in order to return the heart to its correct rhythm. Depending on the level of complexity, this type of procedure can take two to three hours. Each misrouting of the electrical impulses that trigger cardiac arrhythmia, which is measured in milliseconds, must first be located and mapped using electrophysiology catheters. It is only at that point that the doctor can develop an individual treatment plan tailored to the patients' needs. Prof. Osswald has been working with Artis Q.zen since November 2012. "We can now manage with radiation doses that are up to 85 percent below usual values," he says. This benefits both patients and staff alike.

In addition to cardiac arrhythmia, there is another clinical picture in the field of cardiology that is on the rise, and is the most frequent cause of death in the industrialized nations: coronary heart disease. This involves narrowing and blockage of the arteries supplying blood to the heart muscle. In Europe alone, over 1.8 million people die of this chronic disease each year. Narrowings – known as stenoses – can be widened using balloon catheters to restore the flow of blood. Stents keep the constricted locations permanently open. During this procedure, known as percutaneous coronary intervention (PCI), the cardiologist has to position the stent with millimeter precision despite cardiac movement. Using Artis Q.zen, the cardiologist is supported by the advanced guidance of Clearstent Live. With Clearstent Live, stent enhancement takes place in real time. The software eliminates cardiac movement, allowing cardiologists to verify stent positioning relative to the cardiac anatomy or to previously deployed stents. The enhanced images are displayed side-by-side with the current live-image without any noticeable lag and while the operator can still move the balloon mounted stent. In interventions of this nature, Prof. Osswald has observed a clear reduction in dose compared to the previous model, up to 50 percent. "The main advantage is the massively better visualization of the stent and the respective vessel-section. Hence, additional images to decide whether the stent has been fully expanded are no longer necessary," says Prof. Osswald.

Introduced by Siemens during the Radiological Society of North America (RSNA) congress last year, the Artis Q.zen comes with two new advances making it possible to reduce the radiation dose while maintaining and improving the quality – a new x-ray tube and a new detector. The x-ray tube is the only one on the market exclusively equipped with "flat emitter" technology. The new tube permits the system to generate detailed images of moving objects and even the smallest vessels in a beating heart within a very short time at a maximum current of 1,000 milliamperes (mA). The new technology delivers a more richly detailed image for the subsequent treatment.

The new Artis Q.zen detector enables x-ray checks to be performed in the ultra-low dose range, i.e. 20 nanograys (nGy) or less. What is new and unique worldwide is the fact that the detector is based on crystalline rather than on amorphous silicon technology. This is a material of homogenous chemical structure used mainly in the solar industry. It ensures that the image signal is enhanced with substantially reduced electronic noise in the image. This means that the cardiologist can achieve the same image quality using a lower dose.

Follow us on Twitter: www.twitter.com/siemens_press

The Siemens Healthcare Sector is one of the world's largest suppliers to the healthcare industry and a trendsetter in medical imaging, laboratory diagnostics, medical information technology and hearing aids. Siemens offers its customers products and solutions for the entire range of patient care from a single source – from prevention and early detection to diagnosis, and on to treatment and aftercare. By optimizing clinical workflows for the most common diseases, Siemens also makes healthcare faster, better and more cost-effective. Siemens Healthcare employs some 51,000 employees worldwide and operates around the world. In fiscal year 2012 (to September 30), the Sector posted revenue of 13.6 billion euros and profit of 1.8 billion euros. For further information please visit: http://www.siemens.com/healthcare

The products/features (here mentioned) are not commercially available in all countries. Due to regulatory reasons their future availability cannot be guaranteed. Please contact your local Siemens organization for further details.

The statements by Siemens' customers described herein are based on results that were achieved in the customer's unique setting. Since there is no "typical" hospital and many variables exist (e.g., hospital size, case mix, level of IT adoption) there can be no guarantee that other customers will achieve the same results.

Reference Number: HIM201308020e

Contact
Ms. Kathrin Schmich
Healthcare Sector
Siemens AG
Henkestr. 127
91052 Erlangen
Germany
Tel: +49 (9131) 84-5337
Kathrin.Schmich​@siemens.com

Kathrin Schmich | Siemens Healthcare
Further information:
http://www.siemens.com/presse/esc2013

More articles from Medical Engineering:

nachricht UTSA study describes new minimally invasive device to treat cancer and other illnesses
02.12.2016 | University of Texas at San Antonio

nachricht Earlier Alzheimer's diagnosis may be possible with new imaging compound
02.11.2016 | Washington University School of Medicine

All articles from Medical Engineering >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Novel silicon etching technique crafts 3-D gradient refractive index micro-optics

A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.

Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...

Im Focus: Quantum Particles Form Droplets

In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.

“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...

Im Focus: MADMAX: Max Planck Institute for Physics takes up axion research

The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.

The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...

Im Focus: Molecules change shape when wet

Broadband rotational spectroscopy unravels structural reshaping of isolated molecules in the gas phase to accommodate water

In two recent publications in the Journal of Chemical Physics and in the Journal of Physical Chemistry Letters, researchers around Melanie Schnell from the Max...

Im Focus: Fraunhofer ISE Develops Highly Compact, High Frequency DC/DC Converter for Aviation

The efficiency of power electronic systems is not solely dependent on electrical efficiency but also on weight, for example, in mobile systems. When the weight of relevant components and devices in airplanes, for instance, is reduced, fuel savings can be achieved and correspondingly greenhouse gas emissions decreased. New materials and components based on gallium nitride (GaN) can help to reduce weight and increase the efficiency. With these new materials, power electronic switches can be operated at higher switching frequency, resulting in higher power density and lower material costs.

Researchers at the Fraunhofer Institute for Solar Energy Systems ISE together with partners have investigated how these materials can be used to make power...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ICTM Conference 2017: Production technology for turbomachine manufacturing of the future

16.11.2016 | Event News

Innovation Day Laser Technology – Laser Additive Manufacturing

01.11.2016 | Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

 
Latest News

UTSA study describes new minimally invasive device to treat cancer and other illnesses

02.12.2016 | Medical Engineering

Plasma-zapping process could yield trans fat-free soybean oil product

02.12.2016 | Agricultural and Forestry Science

What do Netflix, Google and planetary systems have in common?

02.12.2016 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>